Sharecafe

Prescient Therapeutics (ASX: PTX) – Webinar Presentation

Steven Yatomi-Clarke - CEO & MD - Prescient Therapeutics is focused on developing novel, personalised therapies for a range of cancers.

Steven Yatomi-Clarke – CEO & MD – Prescient Therapeutics is focused on developing novel, personalised therapies for a range of cancers.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories